SYNthesis med chem is a chemistry-focused contract research organization providing custom synthesis and medicinal chemistry services. Established in 2007, the company operates a hybrid business model with expertise in medicinal chemistry and project management in Australia and the USA, while conducting high-quality synthetic chemistry in China. With global headquarters in Melbourne, SYNthesis med chem also has operations in Shanghai and Suzhou, China, as well as offices in the UK and USA. Currently employing over 250 chemists based in Australia, China, and the USA, the company's team includes experienced medicinal chemists and skilled synthetic chemists. The medicinal chemists provide design, innovation, and problem-solving expertise, complementing the synthetic chemists' capabilities. They have managed over 100 projects across all phases of pharmaceutical R&D, emphasizing their track record in delivering clinical candidates and passion for discovering new medicines. Additionally, they act as project managers for custom synthesis and medicinal chemistry projects. SYNthesis med chem's unique business model and global presence position it as a significant player in the contract research organization sector, with potential for further growth and development.
There is no investment information
No recent news or press coverage available for SYNthesis med chem.